Steward Health Care System (Steward), parent company of St. Elizabeth’s Medical Center, has been selected as one of six Accountable Care Organizations (ACOs) in Massachusetts to participate in MassHealth’s Pilot Medicaid ACO program.
November 16, 2016
St. Elizabeth’s is excited to begin construction to enhance our Seton Main Lobby. This project will create a more comfortable and comforting space for our patients and visitors.
Wong is long-time Boston EMS EMT and St. Elizabeth’s Medical Center Emergency Department Technician
September 26, 2016
St. Elizabeth’s Medical Center’s Division of Cardiology began offering a new treatment this week for patients with non-valvular atrial fibrillation (AF) called the Watchman Left Atrial Appendage Closure (LAAC) Implant, an alternative to long-term warfarin medication that is designed to help reduce the risk of stroke in patients with AF.
The Pulmonary Medicine Division at St. Elizabeth’s Medical Center now offers Bronchial Thermoplasty (BT) delivered by the Alair™ System as a safe outpatient bronchoscopy procedure that has been shown to reduce asthma attacks and emergency rooms visits and improve asthma-related quality of life for adult patients with severe persistent asthma.
St. Elizabeth’s Medical Center, a member of Steward Health Care, is pleased to announce that Charles Day, MD, MBA, a nationally renowned expert in hand, wrist and elbow surgery, has joined the Department of Orthopedic Surgery.
August 29, 2016
Steward Guest Internet gives patients, family members and visitors easy access to the Internet. To use the system, you’ll use your own laptop, which must support the 802.11G or G network protocol.
St. Elizabeth’s Medical Center is pleased to welcome Hans Van Lancker, MD, FRCSC, as the Chief of Orthopedic Trauma. Dr. Van Lancker is an accomplished surgeon with experience at two Level I trauma centers as well as a teacher and researcher.
St. Elizabeth’s Medical Center has been recognized by U.S. News & World Report. as one of the best hospitals for 2016-2017 in the Boston Metro area for our treatment of chronic heart failure (CHF).
Just approved by the FDA, the coronary device is the next generation for treating Coronary Artery Disease, with potential to reduce risks to the one million Americans receiving stents annually